AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
.jpg)
Why Evoke Pharma (EVOK) stock soared 139%?
April 27, 2022 03:56 AM AEST| By Versha JainHighlights Evoke Pharma is a specialty pharmaceutical company focused on drugs for treating gastrointestinal disorders and diseases. The US Food and Drug Administration (FDA) has granted new drug product exclusivity for the company.....
Swiss drugmaker Novartis (NVS) Q1 revenue gallops on robust sales
April 27, 2022 12:41 AM AEST| By Team Kalkine MediaHighlights The company posted core operating income of US$4.08 billion. The revenue for its generic drug unit Sandoz was US$538 million. Novartis announced a share buyback program in December 2021. Swiss drugmaker Novartis AG (NYSE: NVS) .....
Why Veru Inc. (VERU) stock surged more than 20% today?
April 26, 2022 05:29 AM AEST| By Versha JainHighlights Veru Inc. (VERU) is a biopharmaceutical company focused on urology and oncology. VERU stock rose 80.51% YTD and 18.88% in one year. The stock has a market capitalization of US$1.03 billion. Shares of biopharmaceuticals co.....
CELU to CMPI: Explore top 5 biotech stocks with over 100% YTD return
April 26, 2022 04:31 AM AEST| By Versha JainHighlights Sierra Oncology, Inc. (NASDAQ: SRRA) stock grew 150.14% year-to- Voyager Therapeutics, Inc. (NASDAQ: VYGR) generated a 17% return YTD. Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) stock rose 257.04% YTD. Biotechn.....
Why Erytech Pharma (ERYP) stock zoomed over 57% on Monday?
April 26, 2022 01:23 AM AEST| By Team Kalkine MediaHighlights: The Erytech Pharma SA (NASDAQ: ERYP) stock shoot up by over 57% in premarket on Monday. Investors took great interest in Erytech’s announcement of selling its US manufacturing facility to Catalent. The ERYP stock closed Frida.....
Walgreens (WBA) shares fall after vaccination slump hit Q2 earnings
April 01, 2022 04:47 AM AEDT| By Team Kalkine MediaHighlights: Walgreens Boots Alliance announces second-quarter results of the fiscal year 2022. Results showed EPS decreased to US$1.02 from US$1.06 in the year-ago quarter. Walgreens bagged strong sales during the winter months, retaine.....
BioNTech (BNTX) to propose special cash dividend after Q4 profits soar
March 31, 2022 03:49 AM AEDT| By Team Kalkine MediaHighlights: BioNTech is likely to propose a special cash dividend of EUR2 (US$2.2) per share at the AGM. The company has delivery orders for 4 billion COVID-19 doses in 2022. It is likely to earmark about EUR1.4 billion to .....
Top healthcare stocks to watch in Q2: ABBV, BMY, ABC, VRTX & MCK
March 30, 2022 05:16 AM AEDT| By Versha JainHealthcare sector companies provide healthcare-related products and services. It is one of the sectors with a complex chain of stakeholders, including drugmakers, medical device makers, medical insurance providers, hospitals, healthcare service pro.....
Why is biotechnology firm Ocugen (OCGN) down in pre-market trading?
March 05, 2022 02:27 AM AEDT| By Rupam RoyHighlights: FDA declined to issue a EUA for Covaxin. The OCGN stock tumbled over 25% in pre-market trading. Ocugen intends to continue its work with the FDA for evaluating the regulatory track for the pediatric utilization of Covaxin. The.....
Top healthcare stocks: ABBV, UNH, LLY, PFE & DHR to explore in March
March 03, 2022 06:12 AM AEDT| By Rupam RoyHighlights AbbVie Inc. (NYSE: ABBV) revenue surged over 7% YoY in Q4, FY21. Pfizer, Inc. (NYSE: PFE) revenue jumped 105% YoY in the fourth quarter of fiscal 2021. Eli Lilly and Co. (NYSE: LLY) fiscal 2021 revenue was up 15% YoY. The healt.....
.jpg)
Why is ZimVie Inc (ZIMV) stock trending?
March 03, 2022 04:16 AM AEDT| By Rupam RoyHighlights Zimmer Biomet said that it completed the spinoff of ZimVie. ZimVie started regular trading on Nasdaq under the ticker "ZIMV". The ZBH stock returned over 3% gains in one month. The stocks of ZimVie Inc. (NASDAQ: ZIMV) began tra.....
What's next for BHC stock as Q4 revenue shrinks?
February 25, 2022 12:38 AM AEDT| By Raza NaqviBausch Health Companies Inc. (TSX:BHC) announced fourth quarter fiscal 2021 and provided guidance for this year. In Q4 2021, total reported revenues of Bausch Health Companies were US$ 2,196 billion compared to US$ 2,213 billion in the fourth quart.....
Meihua (MHUA) stock down 10% after Wednesday’s rally in Nasdaq debut
February 18, 2022 03:39 AM AEDT| By Versha JainHighlights China-based Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA) debuted on Nasdaq Wednesday. The IPO was priced at US$10.00 per share. The stock was up 29% on first-day trading. The China-based Meihua is the fir.....
Why Masimo (MASI) stock plunged 37% today?
February 17, 2022 11:04 AM AEDT| By Versha JainHighlights Masimo Corporation (NASDAQ: MASI) revenue increased by 8.3% in fiscal 2021. The medical technology company is acquiring Sound United for US$1.025 billion. Masimo’s product revenue grew by 11.0% YoY to US$327.6 million .....
Why BioDelivery Sciences (BDSI) stock soared 51% today?
February 15, 2022 04:08 AM AEDT| By Rupam RoyHighlights BioDelivery (BDSI) has entered into a merger agreement with Collegium Pharmaceutical. Collegium will acquire all outstanding BDSI shares at US$5.60 per unit in an all-cash deal. The BDSI stock surged over 14% YTD. Stocks of Bio.....
Top S&P 500 healthcare stocks to watch
February 10, 2022 11:10 AM AEDT| By Rupam RoyHighlights Johnson & Johnson’s (NYSE: JNJ) total sales surged over 10% YoY in Q4, FY21. Pfizer, Inc. (NYSE: PFE) revenue soared 105% YoY in Q4, FY21. Eli Lilly and Company (NYSE: LLY) revenue grew 15% YoY in fiscal 2021. The US .....
Pfizer Inc’s (PFE) 2022 vaccine sales outlook falls short of estimates
February 09, 2022 06:46 AM AEDT| By Versha JainHighlights Pfizer, Inc’s (NYSE: PFE) fiscal 2021-revenue skyrocketed by 95% YoY to US$81.3 billion. Excluding Covid-19 vaccines, the revenue rose around 6% last year on a YoY basis. Pfizer raised the full-year revenue guidance in the ran.....
Can Nuvectis Pharma’s (NVCT) product pipeline, price sway investors?
February 09, 2022 04:14 AM AEDT| By Versha JainHighlights Nuvectis Pharma Inc. (NASDAQ: NVCT) debuted on Nasdaq on February 4, 2022. The stock gained 144.62% gain on February 7. Nuvectis plans to use the proceeds to fund the development of product candidates, such as NXP800, NXP900.....
Amgen Inc (AMGN) CEO Bradway upbeat on growth prospects after results
February 08, 2022 10:47 AM AEDT| By Versha JainHighlights Amgen Inc. (NASDAQ: AMGN) revenue grew 2% to US$26.0 billion in fiscal 2021. Its non-GAAP EPS was US$17.10, up 6% YoY, driven by higher revenue and lower expenses. The stock fell 5.9% in one year. Pharma major Amg.....
Top 7 healthcare stocks on NASDAQ to consider
February 04, 2022 07:23 AM AEDT| By Versha JainHighlights The Omicron virus has renewed focus on the healthcare sector. WHO has warned not to let the guards despite lower hospitalization rate. The Nasdaq Biotechnology Index fell around 19% in one year. The .....
